These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 22949171)

  • 1. MicroRNA-146a suppresses metastatic activity in brain metastasis.
    Hwang SJ; Seol HJ; Park YM; Kim KH; Gorospe M; Nam DH; Kim HH
    Mol Cells; 2012 Sep; 34(3):329-34. PubMed ID: 22949171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneous nuclear ribonucleoprotein C1/C2 controls the metastatic potential of glioblastoma by regulating PDCD4.
    Park YM; Hwang SJ; Masuda K; Choi KM; Jeong MR; Nam DH; Gorospe M; Kim HH
    Mol Cell Biol; 2012 Oct; 32(20):4237-44. PubMed ID: 22907752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing miR-202-3p increases MMP-1 and promotes a brain invasive phenotype in metastatic breast cancer cells.
    Harati R; Hafezi S; Mabondzo A; Tlili A
    PLoS One; 2020; 15(10):e0239292. PubMed ID: 33002044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer.
    Li XF; Yan PJ; Shao ZM
    Oncogene; 2009 Nov; 28(44):3937-48. PubMed ID: 19701247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β-Catenin and NF-κB cooperate to regulate the uPA/uPAR system in cancer cells.
    Moreau M; Mourah S; Dosquet C
    Int J Cancer; 2011 Mar; 128(6):1280-92. PubMed ID: 20473943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer.
    Chang XZ; Li DQ; Hou YF; Wu J; Lu JS; Di GH; Jin W; Ou ZL; Shen ZZ; Shao ZM
    Breast Cancer Res; 2007; 9(6):R76. PubMed ID: 17980029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of notch signaling in a xenograft model of brain metastasis.
    Nam DH; Jeon HM; Kim S; Kim MH; Lee YJ; Lee MS; Kim H; Joo KM; Lee DS; Price JE; Bang SI; Park WY
    Clin Cancer Res; 2008 Jul; 14(13):4059-66. PubMed ID: 18593982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posttranscriptional regulation of urokinase receptor expression by heterogeneous nuclear ribonuclear protein C.
    Velusamy T; Shetty P; Bhandary YP; Liu MC; Shetty S
    Biochemistry; 2008 Jun; 47(24):6508-17. PubMed ID: 18494499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CFTR suppresses tumor progression through miR-193b targeting urokinase plasminogen activator (uPA) in prostate cancer.
    Xie C; Jiang XH; Zhang JT; Sun TT; Dong JD; Sanders AJ; Diao RY; Wang Y; Fok KL; Tsang LL; Yu MK; Zhang XH; Chung YW; Ye L; Zhao MY; Guo JH; Xiao ZJ; Lan HY; Ng CF; Lau KM; Cai ZM; Jiang WG; Chan HC
    Oncogene; 2013 May; 32(18):2282-91, 2291.e1-7. PubMed ID: 22797075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of MMP-1 in breast cancer growth and metastasis to the brain in a xenograft model.
    Liu H; Kato Y; Erzinger SA; Kiriakova GM; Qian Y; Palmieri D; Steeg PS; Price JE
    BMC Cancer; 2012 Dec; 12():583. PubMed ID: 23217186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
    Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
    J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway.
    Ma X; Yan W; Dai Z; Gao X; Ma Y; Xu Q; Jiang J; Zhang S
    Drug Des Devel Ther; 2016; 10():1419-41. PubMed ID: 27143851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA CEBPA-DT promotes liver cancer metastasis through DDR2/β-catenin activation via interacting with hnRNPC.
    Cai Y; Lyu T; Li H; Liu C; Xie K; Xu L; Li W; Liu H; Zhu J; Lyu Y; Feng X; Lan T; Yang J; Wu H
    J Exp Clin Cancer Res; 2022 Dec; 41(1):335. PubMed ID: 36471363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TUG1 knockdown inhibits the tumorigenesis and progression of prostate cancer by regulating microRNA-496/Wnt/β-catenin pathway.
    Li G; Yang J; Chong T; Huang Y; Liu Y; Li H
    Anticancer Drugs; 2020 Jul; 31(6):592-600. PubMed ID: 32427740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monospecific antibody targeting of CDH11 inhibits epithelial-to-mesenchymal transition and represses cancer stem cell-like phenotype by up-regulating miR-335 in metastatic breast cancer, in vitro and in vivo.
    Chen JH; Huang WC; Bamodu OA; Chang PM; Chao TY; Huang TH
    BMC Cancer; 2019 Jun; 19(1):634. PubMed ID: 31248373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-146a inhibits cell migration and invasion by targeting RhoA in breast cancer.
    Liu Q; Wang W; Yang X; Zhao D; Li F; Wang H
    Oncol Rep; 2016 Jul; 36(1):189-96. PubMed ID: 27175941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor Necrosis Factor-Induced miR-146a Upregulation Promotes Human Lung Adenocarcinoma Metastasis by Targeting Merlin.
    Sánchez NC; Medrano-Jiménez E; Aguilar-León D; Pérez-Martínez L; Pedraza-Alva G
    DNA Cell Biol; 2020 Mar; 39(3):484-497. PubMed ID: 31999471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
    Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M
    Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-100 suppresses the migration and invasion of breast cancer cells by targeting FZD-8 and inhibiting Wnt/β-catenin signaling pathway.
    Jiang Q; He M; Guan S; Ma M; Wu H; Yu Z; Jiang L; Wang Y; Zong X; Jin F; Wei M
    Tumour Biol; 2016 Apr; 37(4):5001-11. PubMed ID: 26537584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of circulating miR 802-5p and miR 194-5p and upregulation of brain MEF2C along breast cancer brain metastasization.
    Sereno M; Haskó J; Molnár K; Medina SJ; Reisz Z; Malhó R; Videira M; Tiszlavicz L; Booth SA; Wilhelm I; Krizbai IA; Brito MA
    Mol Oncol; 2020 Mar; 14(3):520-538. PubMed ID: 31930767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.